Medline Industries
Medline Industries, Inc., a leading global manufacturer and distributor of healthcare supplies, is headquartered in the United States. Founded in 1910, the company has established a strong presence in North America and beyond, serving hospitals, nursing homes, and other healthcare facilities. Medline is renowned for its extensive range of products, including surgical instruments, medical apparel, and infection prevention solutions, all designed to enhance patient care and operational efficiency. With a commitment to innovation, Medline has achieved significant milestones, such as expanding its product lines and investing in advanced manufacturing technologies. The company holds a prominent market position, recognised for its quality and reliability, making it a trusted partner in the healthcare industry. Medline's dedication to customer service and tailored solutions further distinguishes it in a competitive landscape.
DitchCarbon Score
How does Medline Industries's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medline Industries's score of 41 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medline Industries's reported carbon emissions
In 2023, Medline Industries reported total carbon emissions of approximately 7,278,301,000 kg CO2e. This figure includes 173,837,000 kg CO2e from Scope 1 emissions, 131,904,000 kg CO2e from Scope 2 emissions, and a significant 6,972,560,000 kg CO2e from Scope 3 emissions. Notably, the Scope 3 emissions primarily stem from purchased goods and services, which accounted for about 5,677,074,780 kg CO2e. Medline has made commitments to reduce its carbon footprint significantly. The company aims to achieve a 30% reduction in both Scope 1 and Scope 2 emissions from a 2023 baseline by 2030. Additionally, Medline is committed to reaching net-zero emissions by 2050, with projections indicating a 42% reduction in total Scope 1 and Scope 2 emissions by 2030, targeting a reduction to 63 tCO2e. For Scope 3 emissions, the company anticipates a 25% reduction, aiming for 513 tCO2e by 2030. In 2021, Medline successfully decreased its absolute emissions by 4% compared to 2020, primarily due to a reduction in Scope 2 emissions. The company is currently evaluating the development of science-based targets and a comprehensive carbon reduction strategy, reinforcing its commitment to sustainability and climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2018 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 45,201,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 81,309,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | 90,611,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medline Industries is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
